Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi’s scalable, proprietary production method. Optimi is also manufacturing MDMA under...